Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 Diabetes

Treatment of type 2 diabetes (T2D) requires progressive therapy intensification to reach and maintain individualized glycemic targets. iGlarLixi, a fixed-ratio combination of insulin glargine 100 U/mL (iGlar) and lixisenatide (Lixi), has been shown to provide robust HbA(1c) reductions allowing more...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Adv Ther
Main Authors: Skolnik, Neil, Del Prato, Stefano, Blonde, Lawrence, Galstyan, Gagik, Rosenstock, Julio
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2021
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8004501/
https://ncbi.nlm.nih.gov/pubmed/33620694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01614-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker